Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal

por Eljack, Sahar, David, Stephanie, Faggad, Areeg, Chourpa, Igor, Allard-Vannier, Emilie
Publicado 2022

Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment

por Eljack, Sahar, David, Stephanie, Chourpa, Igor, Faggad, Areeg, Allard-Vannier, Emilie
Publicado 2022

Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells

por Eljack, Sahar, Allard-Vannier, Emilie, Misericordia, Yoann, Hervé-Aubert, Katel, Aubrey, Nicolas, Chourpa, Igor, Faggad, Areeg, David, Stephanie
Publicado 2022